EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H22ClNO2 |
| Net Charge | 0 |
| Average Mass | 379.887 |
| Monoisotopic Mass | 379.13391 |
| SMILES | CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1 |
| InChI | InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27) |
| InChIKey | UAWXGRJVZSAUSZ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor A lipoxygenase inhibitor that interferes with the action of arachidonate 5-lipoxygenase (EC 1.13.11.34). EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anticonvulsant A drug used to prevent seizures or reduce their severity. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| licofelone (CHEBI:47532) has role analgesic (CHEBI:35480) |
| licofelone (CHEBI:47532) has role anticonvulsant (CHEBI:35623) |
| licofelone (CHEBI:47532) has role antineoplastic agent (CHEBI:35610) |
| licofelone (CHEBI:47532) has role EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor (CHEBI:64964) |
| licofelone (CHEBI:47532) has role EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor (CHEBI:35544) |
| licofelone (CHEBI:47532) has role neuroprotective agent (CHEBI:63726) |
| licofelone (CHEBI:47532) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| licofelone (CHEBI:47532) is a monocarboxylic acid (CHEBI:25384) |
| licofelone (CHEBI:47532) is a monochlorobenzenes (CHEBI:83403) |
| licofelone (CHEBI:47532) is a pyrrolizines (CHEBI:38522) |
| IUPAC Name |
|---|
| [6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid |
| INNs | Source |
|---|---|
| licofelone | WHO MedNet |
| licofelona | WHO MedNet |
| licofelonum | WHO MedNet |
| licofélone | WHO MedNet |
| Synonyms | Source |
|---|---|
| ML 3000 | DrugBank |
| ML3000 | DrugBank |
| ML-3000 | DrugBank |
| 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic acid | ChEBI |
| [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| LCF | PDBeChem |
| DB04725 | DrugBank |
| HMDB0254080 | HMDB |
| Licofelone | Wikipedia |
| CZ20080621 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:156897-06-2 | DrugBank |
| Citations |
|---|